Corient Capital Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,448 shares of VRTX stock, worth $2.23 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

5,448

Previous 5,323 2.35%

Holding current value

$2.23 Million

Previous $1.5 Million 2.33%

% of portfolio

0.11%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $34,228 - $38,191	125 Added 2.35%	5,448 $1.54 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $163,297 - $203,322	695 Added 15.02%	5,323 $1.5 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $170,271 - $200,685	769 Added 19.93%	4,628 $1.21 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $122,844 - $155,074	694 Added 21.93%	3,859 $848,000
Q3 2021 Nov 16, 2021	SELL	$181.39 - $202.99 $83,802 - $93,781	-462 Reduced 12.74%	3,165 $574,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $35,810 - $42,230	191 Added 5.56%	3,627 $732,000
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $29,396 - $34,266	142 Added 4.31%	3,436 $738,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $50,096 - $66,813	242 Added 7.93%	3,294 $779,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $58,032 - $68,803	-227 Reduced 6.92%	3,052 $830,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $58,173 - $76,316	258 Added 8.54%	3,279 $952,000
Q1 2020 May 06, 2020	BUY	$199.77 - $247.81 $71,517 - $88,715	358 Added 13.44%	3,021 $719,000
Q4 2019 Feb 04, 2020	BUY	$166.71 - $223.91 $10,502 - $14,106	63 Added 2.42%	2,663 $583,000
Q3 2019 Nov 06, 2019	BUY	$166.23 - $187.09 $90,096 - $101,402	542 Added 26.34%	2,600 $441,000
Q2 2019 Aug 08, 2019	SELL	$164.61 - $190.37 $98,930 - $114,412	-601 Reduced 22.6%	2,058 $377,000
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $206,299 - $245,322	1,260 Added 90.06%	2,659 $489,000
Q4 2018 Feb 07, 2019	BUY	$151.91 - $192.21 $212,522 - $268,901	1,399 New	1,399 $232,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Vertex Pharmaceuticals Inc Transaction History